Streetbeat News

Stock Prices

IRS

IRSA shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $10.5 to $13.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 2:44 pm

AMAT

Applied Materials, Inc. (NASDAQ:AMAT) is set to release its Q3 earnings on August 15. Analysts expect earnings of $2.02 per share and revenue of $6.67 billion. Recent analyst ratings include Buy and Overweight, with price targets ranging from $235 to $300.

Portfolio Pulse from Avi Kapoor

August 15, 2024 | 2:42 pm

LLAP

LMT

Terran Orbital shares are trading lower after Lockheed Martin signed a definitive agreement to acquire the company.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 2:40 pm

SOWG

Sow Good shares are trading lower following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 2:38 pm

UNG

The latest report on USA natural gas storage shows a decrease of 6 billion cubic feet (BCF), significantly below the estimated increase of 43 BCF and the prior increase of 21 BCF.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 2:38 pm

QIPT

Quipt Home Medical shares are trading lower after the company reported worse-than-expected Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 2:36 pm

HCWB

HCW Biologics shares are trading lower after the company reported a year-over-year decrease in Q2 EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 2:35 pm

TPST

Tempest Therapeutics shares are trading higher following positive feedback from the FDA on their end-of-Phase 2 meeting for amezalpat in combination with atezolizumab and bevacizumab to treat first-line unresectable or metastatic hepatocellular carcinoma.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 2:34 pm

BLRX

BioLineRx shares are trading lower following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 2:34 pm

SPTN

SpartanNash Company (NASDAQ:SPTN) reported Q2 adjusted EPS of 59 cents, beating estimates, but revenues of $2.23 billion missed expectations. Net sales dropped 3.5% due to lower volumes in Wholesale and Retail segments. Despite weaker consumer demand, the company reaffirmed its FY24 guidance. SPTN shares rose 7.3% following the report.

Portfolio Pulse from Nabaparna Bhattacharya

August 15, 2024 | 2:34 pm